431 related articles for article (PubMed ID: 23941498)
1. Targeting protein-bound uremic toxins in chronic kidney disease.
Niwa T
Expert Opin Ther Targets; 2013 Nov; 17(11):1287-301. PubMed ID: 23941498
[TBL] [Abstract][Full Text] [Related]
2. Role of indoxyl sulfate in the progression of chronic kidney disease and cardiovascular disease: experimental and clinical effects of oral sorbent AST-120.
Niwa T
Ther Apher Dial; 2011 Apr; 15(2):120-4. PubMed ID: 21426500
[TBL] [Abstract][Full Text] [Related]
3. The role of carbon adsorbent in the conservative management of chronic kidney disease.
Niwa T
Panminerva Med; 2017 Jun; 59(2):139-148. PubMed ID: 27990791
[TBL] [Abstract][Full Text] [Related]
4. Uremic toxicity of indoxyl sulfate.
Niwa T
Nagoya J Med Sci; 2010 Feb; 72(1-2):1-11. PubMed ID: 20229698
[TBL] [Abstract][Full Text] [Related]
5. Indoxyl sulfate is a nephro-vascular toxin.
Niwa T
J Ren Nutr; 2010 Sep; 20(5 Suppl):S2-6. PubMed ID: 20797565
[TBL] [Abstract][Full Text] [Related]
6. Indoxyl sulfate induces nephrovascular senescence.
Niwa T; Shimizu H
J Ren Nutr; 2012 Jan; 22(1):102-6. PubMed ID: 22200425
[TBL] [Abstract][Full Text] [Related]
7. [Effect of oral sorbent, AST-120, on serum concentration of indoxyl sulfate in uremic rats].
Niwa T; Yazawa T; Maeda K; Ise M; Sugano M; Kodama T; Uehara Y
Nihon Jinzo Gakkai Shi; 1990 Jun; 32(6):695-701. PubMed ID: 2120492
[TBL] [Abstract][Full Text] [Related]
8. Indoxyl sulfate and progression of renal failure: effects of a low-protein diet and oral sorbent on indoxyl sulfate production in uremic rats and undialyzed uremic patients.
Niwa T; Tsukushi S; Ise M; Miyazaki T; Tsubakihara Y; Owada A; Shiigai T
Miner Electrolyte Metab; 1997; 23(3-6):179-84. PubMed ID: 9387112
[TBL] [Abstract][Full Text] [Related]
9. Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.
Liu WC; Tomino Y; Lu KC
Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30208594
[TBL] [Abstract][Full Text] [Related]
10. Role of oxidative stress and indoxyl sulfate in progression of cardiovascular disease in chronic kidney disease.
Fujii H; Nakai K; Fukagawa M
Ther Apher Dial; 2011 Apr; 15(2):125-8. PubMed ID: 21426501
[TBL] [Abstract][Full Text] [Related]
11. Effects of AST-120 on blood concentrations of protein-bound uremic toxins and biomarkers of cardiovascular risk in chronic dialysis patients.
Lee CT; Hsu CY; Tain YL; Ng HY; Cheng BC; Yang CC; Wu CH; Chiou TT; Lee YT; Liao SC
Blood Purif; 2014; 37(1):76-83. PubMed ID: 24576840
[TBL] [Abstract][Full Text] [Related]
12. Preventive effects of an oral sorbent on nephropathy in rats.
Aoyama I; Miyazaki T; Niwa T
Miner Electrolyte Metab; 1999; 25(4-6):365-72. PubMed ID: 10681668
[TBL] [Abstract][Full Text] [Related]
13. [The uremic toxin, indoxyl sulfate, signifies cardio-renal risk and intestinal-renal relationship].
Kiss I
Orv Hetil; 2011 Oct; 152(43):1724-30. PubMed ID: 21983398
[TBL] [Abstract][Full Text] [Related]
14. The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients.
Niwa T; Nomura T; Sugiyama S; Miyazaki T; Tsukushi S; Tsutsui S
Kidney Int Suppl; 1997 Nov; 62():S23-8. PubMed ID: 9350673
[TBL] [Abstract][Full Text] [Related]
15. Serum total p-cresol and indoxyl sulfate correlated with stage of chronic kidney disease in renal transplant recipients.
Huang ST; Shu KH; Cheng CH; Wu MJ; Yu TM; Chuang YW; Chen CH
Transplant Proc; 2012 Apr; 44(3):621-4. PubMed ID: 22483453
[TBL] [Abstract][Full Text] [Related]
16. Removal of protein-bound, hydrophobic uremic toxins by a combined fractionated plasma separation and adsorption technique.
Brettschneider F; Tölle M; von der Giet M; Passlick-Deetjen J; Steppan S; Peter M; Jankowski V; Krause A; Kühne S; Zidek W; Jankowski J
Artif Organs; 2013 Apr; 37(4):409-16. PubMed ID: 23330821
[TBL] [Abstract][Full Text] [Related]
17. Impact of the Oral Adsorbent AST-120 on Organ-Specific Accumulation of Uremic Toxins: LC-MS/MS and MS Imaging Techniques.
Sato E; Saigusa D; Mishima E; Uchida T; Miura D; Morikawa-Ichinose T; Kisu K; Sekimoto A; Saito R; Oe Y; Matsumoto Y; Tomioka Y; Mori T; Takahashi N; Sato H; Abe T; Niwa T; Ito S
Toxins (Basel); 2017 Dec; 10(1):. PubMed ID: 29283413
[TBL] [Abstract][Full Text] [Related]
18. Suppressed serum and urine levels of indoxyl sulfate by oral sorbent in experimental uremic rats.
Niwa T; Miyazaki T; Hashimoto N; Hayashi H; Ise M; Uehara Y; Maeda K
Am J Nephrol; 1992; 12(4):201-6. PubMed ID: 1481866
[TBL] [Abstract][Full Text] [Related]
19. Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography/tandem mass spectrometry and their effects on endothelial ROS production.
Itoh Y; Ezawa A; Kikuchi K; Tsuruta Y; Niwa T
Anal Bioanal Chem; 2012 Jun; 403(7):1841-50. PubMed ID: 22447217
[TBL] [Abstract][Full Text] [Related]
20. Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis.
Niwa T; Ise M
J Lab Clin Med; 1994 Jul; 124(1):96-104. PubMed ID: 8035108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
